THYROID CANCER, PAPILLARY
Clinical trials for THYROID CANCER, PAPILLARY explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER, PAPILLARY trials appear
Sign up with your email to follow new studies for THYROID CANCER, PAPILLARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail may reboot radioiodine in resistant thyroid cancers
Disease control CompletedThis early-phase trial tested whether combining two drugs, vemurafenib and copanlisib, can help radioactive iodine therapy shrink tumors in people with advanced thyroid cancer that no longer responds to standard radioiodine treatment. Only 8 participants with a specific BRAF gene…
Matched conditions: THYROID CANCER, PAPILLARY
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Hidden cancer cells found in neck nodes of small thyroid tumors
Knowledge-focused CompletedThis study looked at 314 patients with small, single thyroid cancers (1-3 cm) that had no signs of spread before surgery. Doctors planned to remove only half the thyroid, but checked lymph nodes during the operation. They found that over half of patients had cancer in those nodes…
Matched conditions: THYROID CANCER, PAPILLARY
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:03 UTC